LiveLeaf
Commercial- Indications
- Diarrhea, Nausea, Gastrointestinal cramps
Company intelligence / Profile preview
LiveLeaf has developed a patented botanical drug platform inspired by innate plant immunity. Their lead technology uses polyphenol-rich extracts to create a prodrug that forms protective molecular barriers at sites of tissue damage, providing anti-infective activity without promoting antimicrobial resistance. Their first commercialized products are supplements for fast relief of digestive distress and diarrhea. There are no published results from formal clinical trials for prescription drugs yet.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on LiveLeaf.